Abstract
Murine Hepatitis Virus Strain 3 (MHV-3) produces fulminant hepatitis with 80–90% mortality in Balb/cJ mice. Previous studies in our laboratory have shown that peritoneal macrophages from MHV-3 infected mice produce a procoagulant (PCA) which has the ability to cleave prothrombin to thrombin (prothrombinase) encoded by the gene fgl2 located on chromosome 5. PCA accounts for sinusoidal thrombosis and hepatic necrosis and the necrosis and mortality can be prevented by treatment of animals with a monoclonal antibody to PCA. These present studies were designed to examine the expression of this gene (mRNA by Northern analysis and in situ hybridization) and the gene product PCA (immunochemistry) in tissues recovered from MHV-3 infected Balb/cJ mice in an attempt to explain the liver specific nature of MHV-3 disease. Fgl2 gene expression was detected as early as 8 hours after MHV-3 infection which persisted to 48 hours in the liver, spleen and lungs whereas no gene expression was seen in the brain or kidneys despite the fact that equivalent viral titers were detected in all tissues at all times. In the liver, fgl2 gene expression was confined to endothelial and Kupffer cells with no expression in hepatocytes. Immunochemistry localized the PCA protein to Kupffer cells and endothelial cells and necrotic foci within the liver. No PCA protein was detected by immunochemistry in any other tissues at any time during the course of MHV-3 infection.
These results explain the liver specific nature (fulminant hepatitis) of MHV-3 infection and provides further evidence for the role of PCA in the pathogenesis of fulminant hepatitis. MHV-3 induces selective transcription of the genefgl2 and only hepatic reticuloendothelial cells produce functional protein (PCA) which is known to account for fulminant hepatic failure produced by MHV-3.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Houtman, J. J., and Fleming, J. O., 1996, Pathogenesis of mouse hepatitis virus-induced demyelination, J. Neurovirol. 2:361–270.
Janousek, J., Strmen, E., and Gervais, F., 1993, Purification of murine Kupffer cells by centrifugal elutriation, J. Immunol. Methods 164:109–117.
Levy, G. A., Leibowitz, J. L., and Edgington, T. S., 1981, The induction of monocyte procoagulant activity by murine hepatitis virus MHV-3 parallels disease susceptibility in mice, J. Exp. Med. 154:1150–1163.
Levy, G. A., Helin, H., and Edgington, T. S., 1984, The pathobiology of viral hepatitis and immunologic activation of the coagulation protease network, Sem. Liver Dis. 4:59–68.
Li, C., Fung, L. S., Crow, A., Myers-Mason, N., Phillips, M. J., Leibowitz, J. L., Cole, E., Ottaway, C. A., and Levy, G. A., 1992, Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection, J. Exp. Med. 176:689–697.
Mori, W., Shiga, J., and Irie, H., 1986, Schwartzman reaction as a pathogenetic mechanism in fulminant hepatitis, Sem. Liver Dis. 6:267–269.
Mori, W., and Naoto, A., 1981, Acute hepatic cell necrosis experimentally produced by viral agents in rabbits, Am. J. Pathol. 103:31–35.
Parr, R. L., Fung, L., Reneker, J., Myers-Mason, N., Leibowitz, J. L., and Levy, G.A., 1995, Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity, J. Virol. 69:5033–5038.
Piazza, M. (ed.) 1969, Experimental viral hepatitis, Charles C. Thomas, Springfield, Illinois.
Pope, M., Rotstein, O., Cole, E., Sinclair, S., Parr, R., Cruz, B., Fingerote, R., Chung, S., Gorczynski, R., Fung, L., Leibowitz, J., Rao, Y. S., and Levy, G. A., 1995, Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication, J. Virol. 69:5252–5260.
Portmann, B., Talbot, I. C., Day, D. W., Davidson, A. R., Murray-Lyon, I. M., and Williams, R, 1975, Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters, J. Pathol. 117:169–181.
Qureshi, S. T., Clermont, S., Leibowitz, J. L., Levy, G. A. and Malo, D., 1995, Mouse hepatitis virus-3 induced prothrombinase (Fgl2) maps to proximal chromosome 5, Genomics 29:307–309.
Ribaudo, R., Gilman, M., Kingston, R. E., Chomczynski, P., and Sacchi, N., 1991, Single-step RNA isolation from cultured cells or tissues, in: Current Protocols in immunology (Supplement 3) (J. E. Coligan, A. M. Kruisbeek, D.H. Margulies, E.M. Shevach and W. Strober, eds.), John Wiley & Sons, Inc., pp. 10.11.7–10.11.14
Seglen, P. O., 1973, Preparation of rat liver cells, Exptl. Cell Res. 82:391–398.
Wang, D., Yeger, H., and Cutz, E., 1996, Expression of gastrin releasing peptide receptor gene in developing lung, Am. J. Repir. Cell Mol. Biol. 14:409–416.
Yuwaraj, S., Cattral, M., Pope, M. and Levy, G. A. 1996, Murine hepatitis virus: Molecular biology and pathogenesis, Viral Hepatitis 2:125–142.
Zimmerman, H. J., and Ishak, K. G, 1982, Valproate-induced hepatic injury: analysis of 23 fatal case, Hepatology 2:591–597.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ding, J.W. et al. (1998). Expression of the fgl2 and Its Protein Product (Prothrombinase) in Tissues During Murine Hepatitis Virus Strain-3 (MHV-3) Infection. In: Enjuanes, L., Siddell, S.G., Spaan, W. (eds) Coronaviruses and Arteriviruses. Advances in Experimental Medicine and Biology, vol 440. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5331-1_79
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5331-1_79
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7432-9
Online ISBN: 978-1-4615-5331-1
eBook Packages: Springer Book Archive